Dr. Abbasi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
One Amgen Center Dr.
Mail Stop 17-1-C
Newbury Park, CA 91320Phone+1 805-447-0238Fax+1 844-447-0238
Education & Training
- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Advanced Cardiac Imaging, 2012 - 2014
- University of Illinois College of Medicine at ChicagoFellowship, Cardiovascular Disease, 2009 - 2012
- University of WashingtonResidency, Internal Medicine, 2005 - 2008
- Saint Louis University School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2019 - 2025
- RI State Medical License 2014 - 2020
- NY State Medical License 2008 - 2016
- IL State Medical License 2009 - 2014
- MA State Medical License 2013 - 2014
Clinical Trials
- Magnesium Supplementation for Primary Prevention of Heart Failure in Obesity Start of enrollment: 2016 Nov 01
- Reversal of Right Ventricular Steatosis in Pulmonary Hypertension Start of enrollment: 2016 Nov 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 269 citationsVisceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study.Ravi V. Shah, Venkatesh L. Murthy, Siddique Abbasi, Ron Blankstein, Raymond Y. Kwong
JACC. Cardiovascular Imaging. 2014-12-01 - 316 citationsCardiac myosin activation with omecamtiv mecarbil in systolic heart failureJohn R. Teerlink, Rafael Diaz, G. Michael Felker, John J.V. McMurray, Marco Metra
The New England Journal of Medicine. 2021-01-14 - 10 citationsA First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients.Peter Winkle, Steven Goldsmith, Michael J Koren, Serge Lepage, Jennifer Hellawell
Cardiovascular Drugs and Therapy. 2023-08-01
Journal Articles
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, David E Lanfear, Thomas M Suter, Narimon Honarpour, Siddique A Abbasi, Fady I Malik, Christopher E Kurtz, The New England Journal of Medicine
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: